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Abstract
Background: Constitutive production of blood coagulation proteins by hepatocytes is necessary for hemostasis. Stressful
conditions trigger adaptive cellular responses and delay processing of most proteins, potentially affecting plasma levels of
proteins secreted exclusively by hepatocytes. We examined the effect of glucose deprivation on expression of coagulation
proteins by the human hepatoma cell line, HepG2.
Methodology/Principal Findings: Expression of coagulation factor VII, which is required for initiation of blood coagulation,
was elevated by glucose deprivation, while expression of other coagulation proteins decreased. Realtime PCR and ELISA
demonstrated that the relative percentage expression +/2 SD of steady-state F7 mRNA and secreted factor VII antigen were
significantly increased (from 100+/215% to 188+/227% and 100+/28.8% to 176.3+/217.3% respectively, p,0.001) at 24 hr
of treatment. The integrated stress response was induced, as indicated by upregulation of transcription factor ATF4 and of
additional stress-responsive genes. Small interfering RNAs directed against ATF4 potently reduced basal F7 expression, and
prevented F7 upregulation by glucose deprivation. The response of the endogenous F7 gene was replicated in reporter
gene assays, which further indicated that ATF4 effects were mediated via interaction with an amino acid response element
in the F7 promoter.
Conclusions/Significance: Our data indicated that glucose deprivation enhanced F7 expression in a mechanism reliant on
prior ATF4 upregulation primarily due to increased transcription from the ATF4 gene. Of five coagulation protein genes
examined, only F7 was upregulated, suggesting that its functions may be important in a systemic response to glucose
deprivation stress.
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Introduction
Hepatocytes produce most of the coagulation proteins found in
plasma, and for many coagulation proteins are the only cell type
known to do so. Though their average concentrations and half-
lives differ, all coagulation proteins are present in trace amounts in
plasma and have comparatively short half-lives. Since sufficient
concentrations of all the coagulation proteins are necessary for
hemostasis, constitutive expression of the genes encoding them is
required to maintain adequate plasma concentrations. Hepato-
cytes must frequently alter their patterns of metabolic gene
expression in response to oscillations in nutrient availability and
the consequent hormonal shifts engendered by normal behaviors
such as feeding or fasting, and by changing levels of activity. In
addition, hepatocytes are responsible for the secretion many
specialized plasma proteins, such as serum albumin and
apolipoproteins, as well as coagulation proteins. However, the
question of whether the rates of coagulation protein transcription
and biosynthesis are consistent, or whether they fluctuate in
response to environmental conditions, has largely been un-
explored.
CoagulationFVII(FVII)playsapivotalroleinbloodcoagulation,
yet has the lowest average plasma level among the vitamin K-
dependent coagulation proteins (500 ng/ml or ,10 nM) as well as
the shortest half-life (3–6 hr). Because of these properties, variations
in the extent of hepatic FVII expression could be particularly
important with regard to hemostasis. FVII is the zymogen of
aglycoproteaseessentialfortheinitialreactionofbloodcoagulation,
and is indispensable for both hemostasis and thrombosis. [1,2]To
initiate blood coagulation, FVII must interact with its trans-
membrane receptor, tissue factor (TF), be converted to its
catalytically active form, FVIIa, and then must proteolytically
activate its physiological substrates, the zymogens of coagulation
factors X (FX) and IX (FIX). [1] These activated coagulation
proteases, in turn, participate in a complex series of reactions with
additional coagulation proteins such as factors VIII and V (FVIII
and FV) on the membrane surfaces of activated platelets or other
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thrombin. The coagulation pathway culminates with the thrombin-
mediatedconversionofsolublefibrinogentoinsolublefibrintoform
the structure of the blood clot. (reviewed in [3,4]) In contrast,
additionalcoagulationproteins,suchasProteinCandProteinS,are
important in counter-reactions that limit the overall extent of blood
coagulation. [5,6].
The interaction between FVII/FVIIa and TF is tightly
regulated by the relative amounts and disparate locations of each
component, as well as by their reciprocal requirements for
functional activation. The plasma concentration of FVII is low,
with 1% of the total amount estimated to be the activated form
(reviewed in [7]). However, FVIIa has negligible catalytic activity
against FIX and FX when in solution; only when bound to TF in
an appropriate cell membrane context does FVIIa attain its full
catalytic ability. Zymogen FVII as well as FVIIa can interact with
TF. After FVII binds TF, it is rapidly converted to FVIIa either
autocatalytically, by the FVII activating protease (FSAP) or by
trace amounts of other activated coagulation proteins. [2,8]
Although TF is more abundant than FVII/FVIIa, being expressed
on the membranes of many cell types throughout the body, it is
found almost exclusively outside the vasculature (reviewed in [9]).
Furthermore, it too exists in an inactive (or ‘‘encrypted’’) form.
[10] Encrypted TF has the ability to bind, but not to support the
catalytic activity of, FVII/FVIIa. [11] The activation (‘‘decryp-
tion’’) of TF has been associated with influx of calcium ions into
TF-expressing cells [12], the local loss of membrane lipid
asymmetry [13], the dissociation of TF dimers [10] and disulfide
exchange at the Cys186–Cys209 bond in the external domain of
TF. [14,15] These physical and biochemical barriers limit the
majority of productive TF–FVII/FVIIa interactions to the time
and place of a vascular injury.
The importance of having sufficient amounts of FVII and TF
for hemostasis has been demonstrated through characterization of
patients with FVII deficiency (TF deficiency has never been
documented in humans [16]), as well as through study of knockout
mice in which one or the other gene has been completely or
partially silenced. Patients homozygous for deleterious promoter
mutations reducing transcription of the FVII gene (F7)
[17,18,19,20,21], although rare, have been diagnosed following
severe bleeding episodes that usually first occur during infancy.
The phenotype of the F7 knockout mouse is reminiscent of that of
patients with severe FVII deficiency. If gestation takes place in
a dam expressing murine FVII from at least one normal allele, the
FVII 2/2 pups develop properly but experience fatal internal
hemorrhages shortly after birth. [22,23] Ablation of the TF gene is
an embryonic lethal defect [24,25], but normal development takes
place in mice expressing very low TF levels, ,1% of the typical
level. Hemostasis is apparently normal in this ‘‘low-TF’’ mouse,
except in situations where extensive bleeding must be controlled.
[24].
The endoplasmic reticulum (ER) is an important organelle
within all eukaryotic cells, and its proper functioning is especially
significant for differentiated cell types such as hepatocytes that
must meet continual heavy metabolic and biosynthetic demands.
In hepatocytes, the roles of the ER include the maintenance of
intracellular calcium levels, the production of membrane lipids
and cholesterol, the metabolism of glycogen, the detoxification of
both xenobiotics and the byproducts of normal metabolism such as
lactate and ammonia, as well as the synthesis, initial folding and
post-translational modification of an array of specialized trans-
membrane and secreted proteins. As secreted proteins, FVII and
other coagulation factor proteins must traverse the hepatocyte ER
during biosynthesis. Many circumstances, both physiologic and
pharmacologic, have been shown to compromise the ability of the
ER to optimally handle protein synthesis, and as a cell type with
high protein secretory activity, hepatocytes may be particularly
sensitive to conditions that trigger cellular stress responses. [26] A
common repercussion of such insults is a sharp reduction in global
protein translation, which lessens the cell’s energetic burden at
a time when resources are limited. Translational inhibition comes
about through the reversible phosphorylation of the eukaryotic
translation initiation factor 2 alpha (eIF2a) at a single residue,
impairing its ability to interact with GTP and blocking binding of
the initiator methionyl-transfer RNA to ribosomes, thus inhibiting
new protein translation. [27,28,29,30,31].
At least four kinases are known to be capable of phosphorylating
eIF2a, thereby repressing global protein synthesis in response to
different types of stress: these are HR1 (EIF2AK1), PKR
(EIF2AK2), PERK (EIF2AK3), and GCN2 (EIF2AK4). HR1 is
known to be activated by oxidative stress, PKR by viral infection,
PERK by damage to the ER or by accumulation of misfolded
proteins within it, and GCN2 by amino acid deprivation or UV
irradiation [29,31,32,33,34] In addition to the immediate re-
duction in global protein synthesis, gene expression patterns are
altered in stressed cells to bring about a longer-term response to
the stressor. Paradoxically, phosphorylated eIF2a also enhances
the selection of the appropriate open reading frame in the
messenger RNA encoding the transcription factor ATF4 (activat-
ing transcription factor 4) and so preferentially increases ATF4
translation at a time when overall protein translation is inhibited.
The resultant increase in ATF4 functionality is succeeded by the
upregulated expression of numerous ATF4 target genes, many but
not all of which also encode transcription factors.
[35,36,37,38,39,40,41,42,43,44,45,46] Collectively, this eIF2a-
mediated mechanism has been referred to as the ‘‘integrated
stress response’’ [47].
Conditions that interfere directly with ER functioning, causing
unfolded nascent proteins to accumulate within it, activate
additional stress response pathways. Three ER transmembrane
proteins–an eIF2a kinase mentioned above (PERK, or protein
kinase RNA-dependent-like endoplasmic reticulum kinase), ATF6
(activating transcription factor 6) and IRE1a (inositol requiring
enzyme 1 alpha)–mediate the three branches of the ER stress
response (reviewed in [48]). In homeostasis, the ER luminal
domains of each of these proteins is thought to be bound by GRP-
78 (glucose related protein 78, also known as BiP) an abundant ER
chaperone protein, and this interaction maintains them in their
inactive states. When improperly folded proteins accumulate
within the ER, there is an increased need for GRP-78 to act as
a chaperone and so it dissociates from PERK, ATF6 and IRE1a.
For each of these ‘‘sensor proteins’’, its dissociation from GRP-78
is the prerequisite for activation. [49] PERK is activated by
dimerization and autophosphorylation [50] early in the stress
response. Inactive ATF6 is translocated from the ER to the Golgi
apparatus following its dissociation from GRP-78, where it is
cleaved by SP1 and SP2 (the resident site-1 and site-2 proteases) to
release the active ATF6a transcription factor. [51] After trans-
location to the nucleus, ATF6a, in conjunction with the
transcription factor NF-Y, upregulates expression of target genes
that include the chaperone proteins GRP-78, GRP-94 and PDI
(protein disulfide isomerase), as well as of transcription factor
XPB1 (X-box binding protein 1). Although production of ATF6a
is fairly rapid, the subsequent upregulation of its target genes
requires some time to become apparent. Finally, when IRE1a is
released from GRP-78, it dimerizes and is autophosphorylated,
activating an internal endoribonuclease. [50] Two functions for
the IRE1a ribonuclease have been reported: the degradation of
Glucose Deprivation Upregulates F7
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reduces the protein synthetic burden of the ER, [52] and atypical
splicing of XPB1 mRNA. Translation of unspliced XBP1 mRNA
produces a DNA binding protein without a transactivation
domain. When the IRE1a ribonuclease removes a 26-base pair
intron from XPB1 mRNA, the reading frame is altered to encode
a fully functional transcription factor. [53,54,55] Many target
genes of XPB1 overlap with those of ATF6a, while others promote
the degradation of misfolded proteins. This third branch of the ER
stress response is the last to be fully implemented, since a significant
level of XBP1 mRNA is not attained prior to upregulation of the
XBP1 gene by ATF6a. [54] The co-ordinated activation of these
pathways thus limits global protein synthesis by blocking the
translation of most proteins, producing additional protein chaper-
ones to assist with the folding of immature proteins within the ER
lumen, and enhancing the degradation of mRNAs and severely
misfolded proteins. Although higher-level activation of stress
response pathways, especially if sustained over time, will lead to
apoptosis, these mechanisms taken together are well suited to
resolve short-term or lower-intensity stresses that cause unantic-
ipated difficulties with protein synthesis. [56].
Investigations of cellular stress responses have largely been
directed towards detailed understanding the intracellular pathways
involved, and have seldom explored the effect of stresses upon the
expression of cell-type specific secreted proteins. The expected
slowdown in global protein processing characteristic of stress
responses, together with possible reductions in mRNA and nascent
protein stability, suggest that production of all secretory proteins
would be curtailed. In this study, we have examined whether stress
triggered by glucose deprivation influenced expression of five
coagulation protein genes–those encoding the vitamin K-de-
pendent FVII, FX, prothrombin and protein S, as well as FVIII, in
the human hepatoma cell line, HepG2.
To our knowledge, no previous investigation has analyzed the
extent to which nutritional stress impinges on constitutive
expression of blood coagulation proteins. Our results indicated
that 24 hr glucose deprivation activated multiple stress response
pathways in HepG2 cells, and was associated with reduced mRNA
levels transcribed from the F10, F2 (prothrombin), PROS1 (protein
S) and F8 genes. Conversely, however, we found that the
expression of the F7 gene was enhanced at both the mRNA and
the secreted protein levels by glucose deprivation. Focusing on F7
transcriptional upregulation, we further demonstrate that it occurs
in an ATF4-dependent manner, mediated by increased transcrip-
tion of the ATF4 gene and direct interaction of ATF4 protein with
a composite binding element within the proximal promoter of the
F7 gene.
Results
Glucose Deprivation Differentially Affects Expression of
Coagulation Protein Genes
To examine the ability of glucose deprivation to influence the
expression of coagulation factor genes, HepG2 cells were
incubated in standard culture media supplemented with 1% fetal
bovine serum and glucose at high, standard, or no-glucose
conditions (25 mM, 5 mM and 0 mM glucose, respectively). It
was anticipated that glucose deprivation would activate the
integrated stress response and thus increase the amount of
functional ATF4 transcription factor present in the cells.
Therefore, this initial experiment was performed upon cells that
had been transfected either with a negative control siRNA or with
a validated siRNA directed against ATF4. After 24 hr of
treatment, total RNA was isolated, converted to cDNA, and
tested by quantitative reverse-transcriptase realtime PCR as shown
in Figure 1, to determine the relative levels of mRNA encoding the
genes of interest: several coagulation factor genes, the ATF4 gene
and a number of its target genes, and additional known stress-
inducible genes. A complete list of the genes examined, their
genebank accession numbers, and the Taq-Man gene expression
assay numbers used, are given in Table S1.
With regard to expression of the coagulation factor genes
(Figure 1A), the data demonstrate that in cells transfected with the
negative control siRNA, the F10, F2 (prothrombin), PROS1 and F8
genes were each significantly downregulated at the mRNA level by
glucose deprivation. In contrast, the expression of F7 steady-state
mRNA was significantly upregulated by glucose deprivation, from
100+/215% to 188+/227%. Glucose deprivation for 24 hr also
increased expression of the ATF4 gene at the mRNA level
(Figure 1B). The steady-state ATF4 mRNA was elevated nearly
two-fold (from 100+/215.7% to 178+/229.3%). These data
suggested that ATF4 transcription was elevated, while the
increased expression of several recognized, stress-inducible target
genes of ATF4 (ASNS, C/EBPb, ATF3) (Figure 1C) implied that
ATF4 protein levels and transcriptional capacity had also been
elevated during glucose deprivation.
Increased mRNA levels were also observed for two ‘‘growth
arrest and DNA damage-inducible’’ or GADD genes: CHOP
(GADD153), an inhibitory member of the C/EBPb transcription
factor family, and GADD34, an accessory protein for the serine/
threonine-protein phosphatase PP1 which is needed to reverse the
stress-induced repression of protein synthesis mediated by
phosphorylated eIF2a. [57] In addition, increased mRNAs
encoding the transcription factors ATF6 and spliced XBP1(S)
despite a decrease in total XPB1(U) mRNA, and of the ER
chaperone protein GRP-78, were also observed. (Figure 1B, 1C)
These data indicated that all ER stress response pathways, not
only the integrated stress response, had been triggered in the cells
by glucose deprivation.
The inclusion of ATF4 siRNA reduced the mRNA levels of
some genes in this panel, indicating the ones whose basal and/or
induced expression relied upon functional ATF4. Glucose
deprivation in the presence of ATF4 siRNA blocked basal ATF4
mRNA expression as well as ATF4 upregulation during glucose
deprivation, and also prevented the upregulation of C/EBPb,
ATF3, and ASNS. In contrast, ATF4 siRNA had only minimal
influence on the induction of GADD34, GRP-78 and CHOP.
Interestingly, ATF4 siRNA blocked ATF6 induction, and partially
prevented the increased splicing of XBP1(S) during glucose
deprivation as well. Crosstalk has been previously reported
between the integrated stress response and these other branches
of the ER stress response. [58,59].
ATF4 siRNA did not significantly affect the basal expression, or
prevent the downregulation during glucose deprivation, of the
coagulation protein genes F10, F2, PROS1 and F8. Of the
coagulation factor genes tested, only F7 responded to ATF4
siRNA, and its responses were strong and were observed at all
three glucose concentrations. The F7 steady-state mRNA levels
were halved by inclusion of ATF4 siRNA in comparison to the
negative control siRNA, at both 25 mM and 5 mM glucose. Most
notably, inclusion of ATF4 siRNA completely eliminated the
increase in F7 mRNA anticipated at 0 mM glucose. The response
of F7 to the ATF4 siRNA resembled more closely that of ASNS
and of the ATF4 gene itself, than it did even of two other known
ATF4 target genes, ATF3 and C/EBPb. Taken together, the data
of Figure 1 implied a previously unrecognized role for ATF4 in
endogenous expression of F7, and suggested as well that F7 is
a transcriptional target of ATF4 during the integrated stress
Glucose Deprivation Upregulates F7
PLoS ONE | www.plosone.org 3 July 2012 | Volume 7 | Issue 7 | e40994Figure 1. Glucose deprivation and coagulation factor mRNA expression. Replicate cultures of HepG2 cells were transfected with negative
control siRNA (grey bars) or ATF4 siRNA #1 (white bars), then cultured in media with 25 mM, 5 mM, or 0 mM glucose for 24 hr. RNA was analyzed by
qRT-PCR for expression of amplicons as shown. For each amplicon, average expression at 25 mM glucose with the negative control siRNA was
considered 100% and other values are shown as % expression +/2 SD relative to that. N=3 per group. Panel A, coagulation factor genes; panels B
and C, stress responsive genes. At 0 mM glucose, expression was significantly increased for F7, ATF4, ATF6, XBP1(S), GADD34, GRP-78, ASNS, C/EBPb,
ATF3 and CHOP (all p,0.001). Please note difference in scale between panel A and panels B and C. ATF4 siRNA blocked all increases (all p,0.005)
except for GRP-78, GADD34 and CHOP. Expression of FX, F2 and PROS1 were significantly decreased at 0 mM glucose (all p,0.001) and were not
significantly affected by ATF4 siRNA.
doi:10.1371/journal.pone.0040994.g001
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these topics in more detail.
Thapsigargin and Glucose Deprivation Trigger Similar
Stress Responses, but have Distinct Effects on F7
Expression
Thapsigargin (TG), an irreversible inhibitor of the ER-
membrane calcium ATPase, interferes with normal ER function-
ing and provokes strong and rapid activation of all branches of the
ER stress response. [45,49,51,60] A TG concentration of 500 nM
and a time of 6 hr were chosen for the comparison to 24 hr
glucose deprivation for HepG2 cells, since in each instance ATF4
expression was roughly doubled. In Figure 2, the ability of TG to
affect gene expression was compared to that of glucose depriva-
tion. Panels A and B provide the results of qRT-PCR performed in
parallel for a number of stress-inducible genes. As in glucose
deprivation (Figure 1, and confirmed here) ATF4 and its target
genes ATF3, C/EBPb, and ASNS, as well as GADD34 GRP-78,
XBP1(U) and XBP1(S) were all significantly upregulated by TG.
ATF3, ASNS, GADD34 and GRP-78 were increased to a greater
extent by glucose deprivation than by TG; CHOP and C/EBPb
were increased to approximately the same extent; and XBP1(U)
and XBP1(S) were increased to a greater extent by TG than by
glucose deprivation. Only glucose deprivation increased expres-
sion of ATF6. Finally, as shown in panel C, it was striking that TG
had no effect at all on expression of the two coagulation factor
genes tested: F7 was not upregulated, nor was F8 downregulated,
as they were by glucose deprivation.
In Figure 2 panel D, protein expression for a subset of these
stress-responsive genes (ATF4, ATF3, CHOP, and XBP1(S)) were
investigated, along with pan- and phospho-eIF2a. Both glucose
deprivation and TG treatment increased the detectable amounts
of ATF4 and ATF3, while CHOP and XBP1(S) were increased by
glucose deprivation at the protein level, corroborating their
expression at the mRNA level. While the amounts of total eIF2a
remained fairly constant, we noted that higher amounts of
phospho-eIF2a were seen at 25 mM and 5 mM glucose than at
0 mM glucose and 500 nM TG. This result appeared contradic-
tory, since the greatest detection of phospho-eIF2a might have
been expected under the strongest stress conditions. However, we
also noted that mRNA expression of GADD34, which assists PP1 to
dephosphorylate eIF2a and thereby permits global protein
translation to resume, was also much higher under glucose
deprivation (3271+/2309%) or TG treatment (1015+/2205%)
than at 25 mM or 5 mM of glucose (100+/217.6% and 112+/
215.2%, respectively). Thus we hypothesized that eIF2a had been
extensively phosphorylated (or was being repeatedly yet transiently
phosphorylated) in glucose-deprived and TG-treated cells, but that
its phosphorylation status was being reversed through induction of
GADD34.
To test this hypothesis, we performed an additional experiment
in which cells were cultured for 6 hr with 5 mM or 0 mM glucose,
in the absence versus the presence of the specific PP1 inhibitor,
Sal003. [61] Because the eIF2a dephosphorylation mechanism is
inhibited, any phospho-eIF2a generated under glucose depriva-
tion will accumulate when Sal003 is included. The Western blot
comparing eIF2a and phospho-eIF2a under these conditions is
shown in Figure 3. Approximately comparable amounts of
phospho-eIF2a were detected in cells cultured with 5 mM or
0 mM glucose in the absence of Sal003 (compare lanes 1 and 2).
At 5 mM glucose, the detectable phospho-eIF increased slightly
when 10 mM Sal003 was present during the incubation period
(compare lanes 2 and 4). However, the detectable phospho-eIF2a
increased robustly in cells cultured with 0 mM glucose and 10 mM
Sal003 (compare lanes 1 and 3). It is interesting to note that even
under the standard culture conditions, eIF2a was phosphorylated
to a minor degree, and hence was capable of enhancing the
translation of ATF4 mRNA somewhat. These data indicate that
Figure 2. Thapsigargin versus glucose deprivation and F7
mRNA expression. (A-C) HepG2 cells were treated in parallel for
24 hr in medium with 25 mM, 5 mM or 0 mM glucose (white bars, with
the direction of arrows indicating decreasing concentration) or for 6 hr
at 5 mM glucose without (-) or with (+) 500 nM TG (grey bars), and qRT-
PCR was performed as described. Expression at 25 mM glucose and
without thapsigargin were considered 100% expression for each
amplicon; other groups were expressed as a percentage +/2 SD
relative to this. N=3/group. Glucose deprivation significantly increased
expression of ATF4, ATF6, ASNS, C/EBPb, XBP1(S), GRP78, CHOP, GADD34,
and F7 (all p,0.001). TG did likewise (all p,0.001), except for ATF6 and
F7 amplicons. F8 was downregulated by glucose deprivation but
unaffected by TG. (D) Western blot of whole-cell extracts of cells treated
with glucose and/or TG as shown, above the lanes, for detection of the
proteins shown at the right.
doi:10.1371/journal.pone.0040994.g002
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glucose deprivation, implying that enhanced transcription of the
ATF4 gene and preferential translation of ATF4 mRNA cooperate
in the upregulation of F7 and other ATF4 target genes.
FVII is Secreted in an ATF4-dependent Manner during
Glucose Deprivation
To determine the extent to which the elevation in F7 mRNA in
response to glucose deprivation was reflected in translation and
secretion of FVII antigen, HepG2 cells were incubated in media
with glucose levels ranging from 25 mM to 0 mM, and the
amount of FVII secreted into the culture medium over a 24 hr
period was measured by ELISA (Figure 4). Glucose at 25 mM,
5 mM, and 1 mM were employed to mimic the plasma glucose
levels in unregulated diabetics, and in non-diabetics during fed and
fasted states, respectively. [62] Though unlikely to occur in
physiological contexts, the glucose deprivation condition (0 mM
glucose), was included as an established method to strongly
provoke cellular stress responses, [41,42,45,46] the efficacy of
which we had confirmed, above. Low glucose concentrations,
either 1 mM or 0 mM, significantly increased the amount of FVII
antigen detected in the culture medium. For cells in media
containing 10% serum, reduction of glucose from 25 mM to
1 mM increased the amount of secreted FVII from 100+/210.5%
to 159.7+/217.2% (p,0.001). For cells in media containing 1%
serum, reduction from 25 mM to 0 mM glucose increased FVII
antigen from 100+/28.8% to 176.3+/217.3% (p,0.001). In
these experiments, any insulin present was contributed by the
serum component of the media and was constant under a given
condition. Since glucose limitation increased the secreted FVII
regardless of the amount of serum present, this effect was
independent of insulin or any other serum component. For
convenience, subsequent experiments were performed in media
containing 1% serum.
As a control to examine whether glucose deprivation treatments
were survivable, we have measured both the cell number and the
overall metabolic activity by a colorimetric MTS (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium) assay in cells cultured for 24 hr in media with
1% serum containing either 5 mM or 0 mM glucose. (Figure S1).
While there was a notable reduction in metabolic activity, from
100+/210% to 13+/21.4%, associated with glucose deprivation,
this was not accompanied by a reduction in cell number. Thus we
concluded that the F7/FVII induction provoked by the glucose
deprivation was likely to be part of an adaptive response to a severe
but survivable stress condition.
ATF4 Increases F7 Expression by Direct and Indirect
Mechanisms
As described above, an important early event in cellular stress
responses is preferential translation of ATF4 mRNA at the correct
ORF to produce the functional transcription factor. This may also
be accompanied by elevated transcription of the ATF4 gene as
noted by other investigators and as we observed for both glucose
deprivation and TG (Figures 1 and 2) [35,41,45,47,56]. Whether
ATF4 directly affected transcription of the F7 gene, either under
basal conditions or during the stress response, was not previously
known.
The results of our initial experiment suggested that ATF4
influenced F7 transcription under both basal circumstances and
during glucose deprivation. To investigate this more closely, we
first employed an RNA interference strategy to assess the degree to
which ATF4 influences ambient F7 expression in unstressed cells.
As shown in Figure 5A, the endogenous ATF4 expressed by
HepG2 cells under the standard culture condition of 5 mM
glucose was independently knocked down by two small interfering
RNAs (siRNAs), one directed to the 5’ UTR and the other to the
3’ UTR, of the ATF4 gene.
The data of Figure 5A demonstrate that each ATF4 siRNA was
effective in reducing the steady-state ATF4 mRNA to ,30% of
Figure 3. Phosphorylation of eIF2a during glucose deprivation.
Western blots of extracts from HepG2 cells incubated for 6 hr in media
having either 0 mM or 5 mM glucose, and without (-) or with (+)1 0mM
Sal003 as shown above lanes. Antibodies against phospho-eIF2a
(eIF2a,P), total eIF2a and GAPDH as a loading control, were used as
indicated to the right of each blot.
doi:10.1371/journal.pone.0040994.g003 Figure 4. Glucose concentration affects secreted FVII antigen
levels. HepG2 cells were cultured for 24 hr in media supplemented
with 10% or 1% fetal bovine serum and either high (25 mM), standard
(5 mM), or low/no (1 mM or 0 mM) glucose. The concentration of
secreted FVII antigen, expressed as ng per ml, was determined by ELISA.
For each experimental set, the average amount secreted by cells in
25 mM glucose was considered 100%, and amounts secreted at the
lower glucose concentrations were expressed as percentages +/2 SD
relative to that. The number of replicates assayed at each condition is
shown below the bars. Reducing the concentration of glucose
significantly increased the amount of FVII secreted for each experi-
mental set (p,0.001).
doi:10.1371/journal.pone.0040994.g004
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At the same time, each ATF4 siRNA decreased F7 steady-state
mRNA to ,60% of its level in cells transfected with the negative
control siRNA. The western blot of Figure 5B for ATF4 protein
expression and the ELISA of Figure 5C for FVII antigen secretion
demonstrate that transfection with ATF4 siRNA caused a re-
duction in the ATF4 and F7 protein levels reflecting their
respective mRNA reductions. The amount of detectable ATF4
protein, assessed by Western blotting of whole-cell extracts,
declined dramatically post-introduction of ATF4 siRNA. Similar-
ly, introduction of ATF4 siRNA reduced the cumulative amount
of FVII secreted into conditioned media as assessed by ELISA,
from 100+/29.5% to 76.1+/26.3%, p,0.001. These data clearly
indicate that even under the standard growth conditions, un-
stressed HepG2 cells were expressing endogenous ATF4, and that
the extent of ATF4 expression was positively correlated with that
of F7.
We have previously demonstrated that F7 expression is
modulated in response to insulin, via a promoter element that
interacts with transcriptionally activating and inhibiting isoforms
of C/EBPb. [63] Because C/EBPb is known to be upregulated by
ATF4 during nutritional stress [36,42], and because the data of
Figures 1 and 2 suggest that C/EBPb expression is ATF4
dependent during glucose deprivation, our data could not
differentiate whether the increase in transcription of the F7 gene
was a direct effect of ATF4 upregulation, or an indirect effect
mediated by ATF4-dependent upregulation of the C/EBPb gene.
To address whether or not fluctuating ATF4 expression influenced
F7 directly or indirectly, we assessed the individual effects of C/
EBPb siRNA versus ATF4 siRNA on F7 expression during glucose
deprivation. (Figure 6) The data presented in both panels of
Figure 6 again corroborated the upregulation of the ATF4, F7, and
C/EBPb genes by glucose deprivation in the presence of negative
control siRNA. Reduction of glucose from 25 mM to 5 mM had
negligible effects on expression of all three genes. In contrast, the
further reduction from 5 mM to 0 mM glucose significantly
increased their relative expression levels. For the ATF4 and F7
genes, steady-state mRNA levels were approximately doubled by
glucose deprivation, while for C/EBPb they were approximately
quadrupled. Introduction of ATF4 siRNA prior to glucose
deprivation (Figure 6A) once again completely prevented upregu-
lation of both ATF4 and F7, and significantly reduced but did not
block upregulation of C/EBPb. In contrast, while introduction of
C/EBPb siRNA prior to glucose deprivation did interfere with the
extent of both C/EBPb and F7 upregulation, it did not prevent
induction of ATF4 by glucose deprivation (Figure 6B). Further,
since ATF4 knockdown completely blocked F7 induction by
glucose deprivation, but C/EBPb knockdown did not, we
concluded that the response of the F7 gene to glucose deprivation
was taking place partially but not solely via an intermediate, C/
EBPb-dependent mechanism, and partially via a direct ATF4-
dependent mechanism.
Glucose Deprivation Drives F7 Reporter Gene Expression
through the AARE Motif
Stress-induced increases in expression of many ATF4 target
genes are known to be mediated by interactions of transcriptional
regulatory proteins with an ‘‘amino acid response element’’, or
Figure 5. ATF4 siRNA blocks basal F7 expression. A. siRNA directed to either the 5’ UTR (ATF4 si#1, white bars) or the 3’ UTR (ATF4 si#2,
striped bars) of the human ATF4 gene were introduced into HepG2 cells cultured in media with 5 mM glucose. Parallel cultures were transfected with
the same amount of negative control siRNA (control si, light and dark grey bars, respectively). Relative expression of ATF4 and F7 are graphed as
a percentage +/2 SD of the expression seen with negative control siRNA, which was considered 100%. For ATF4 si#1, N=5 for ATF4 amplicon and
N=10 for F7 amplicon; for ATF4 si #2, N=6 per group. All p,0.001 for both ATF4 siRNAs. B. Whole-cell extracts prepared from HepG2 cells
transfected with negative control siRNA (control si), 5’ UTR-ATF4 siRNA (ATF4 si#1) or without siRNA (none) and cultured 48 hr in media with 5 mM
glucose. Replicate aliquots of extracts, 4 mg/lane, were separated on SDS-PAGE and Western-blotted in parallel with antibody to ATF4 (upper panel)
or to GAPDH (lower panel) as loading control. C. Conditioned media collected from cells following transfection with negative control siRNA (dark
grey bars) or ATF4 si#2 (striped bars) for 48 hr in media with 5 mM glucose, analyzed for FVII antigen by ELISA. N=18/group, p,0.001.
doi:10.1371/journal.pone.0040994.g005
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within 59 and 39 regulatory regions, as well as within introns, of
several stress-inducible genes. [36,37,38,39,40,41,42,43,44,45,46]
AAREs have also been shown to interact with transcription factors
of the basic leucine-zipper (b-zip) superfamily, of which both the
CCAAT enhancer binding proteins (C/EBPs) and the activating
transcription factors (ATFs) and are members. [44,64,65] Our
previous work had shown that the F7 promoter includes an AARE
between positions 28 and +1 of the F7 promoter (where +1
represents the first base of the initiator methionine codon of the
FVII structural gene), and that C/EBPb affects F7 expression via
this element. [63]Thus we hypothesized that the glucose-depriva-
tion dependent F7 upregulation might be mediated, at least in
part, via the AARE.
To test this hypothesis, the responsiveness of the endogenous F7
gene to ATF4 was modeled in a reporter gene system. Reporter
constructs containing a fragment of the human F7 gene extending
spanning the AARE were prepared in native and block-mutated
configurations. The unmutated AARE has base sequence 59
ATTTCATCA 39, and like other identified AAREs appears to be
a composite element with one half-site (residues –8 to –4, 59
ATTTC 39) resembling a C/EBP monomer consensus juxtaposed
to a second half-site (residues –3 to +1, 59 ATCA 39) resembling an
ATF monomer consensus. The block-mutated (DAARE) con-
struct, with sequence 59 ATGAGCGCA 39, has base changes
introduced at positions 22 through 26 to disrupt both half-site
motifs. These plasmids, along with a promoterless control plasmid,
were then used for various transient tranfection assays in HepG2
cells to assess responses to pre-existing endogenous ATF4 under
the standard 5 mM glucose condition (Figure 7A), to induction of
endogenous ATF4 by glucose deprivation (Figure 7B), and to
overexpression of recombinant human ATF4 (Figure 7C).
In Figure 7A, HepG2 cells were cotransfected with the AARE-
WT, DAARE, or promoterless control pOGH plasmids, along
with either negative control siRNA or ATF4 siRNA, and cultured
at the standard 5 mM glucose concentration. Reporter expression
from the promoterless vector, as well as from the block-mutated
vector, were not significantly changed by the presence of the ATF4
siRNA compared to the presence of the negative control siRNA.
However, the extent of reporter expression from the native
construct was reduced in the presence of the ATF4 siRNA. This
reduction was significant although its increment was small, from
100+/27.8% to 81.8+/28.5%, p,0.001. In Figure 5B, the same
reporter constructs were transfected into HepG2 cells prior to
24 hr treatment with 25 mM, 5 mM or 0 mM glucose. While
reporter expression from the native construct increased signifi-
cantly due to glucose deprivation (from 100+/29.2% to 228+/
256%, p,0.001), expression from the promoterless control and
DAARE constructs were unaffected.
In the experiments of Figures 7A and 7B, the unmutated F7
reporter gene recapitulated the responses of the endogenous F7
gene to ATF4 silencing under both ambient and glucose
deprivation conditions. In contrast, the block-mutated reporter
gene was inert both to reduction of ambient ATF4 by ATF4
siRNA and to induction of ATF4 by glucose deprivation,
identifying the AARE as the promoter region required for the
responses of the F7 gene to ATF4.
In Figure 7C, the responsiveness of the native, block-mutated,
and half-site mutated reporter constructs to overexpression of
recombinant human ATF4 was assessed. For the native construct,
the dose-responsive increase in reporter expression to recombinant
ATF4 was robust. However, installation of double point mutations
within either the ATF-motif (DA, with changes at positions 22
and 23), or the C/EBP-motif (DC, with changes at positions 26
and 27), as well as the block mutation affecting both motifs,
severely impaired the influence of recombinant ATF4 on reporter
expression. While all three mutated constructs responded weakly
to recombinant ATF4, they were severely impeded in the extent of
reporter upregulation in comparison to the construct with an
unmutated AARE. Taken together, the data of Figure 5 confirmed
that the effect of ATF4 on F7 expression occurred through the
Figure 6. ATF4 siRNA and C/EBPb siRNA differentially block F7 induction. A. Replicate cultures of HepG2 cells were transfected with ATF4
siRNA #2 (grey bars), or negative control siRNA (black bars), then cultured with 25 mM, 5 mM, or 0 mM glucose for 24 hr. qRT-PCR was done for
expression of ATF4, F7, and C/EBPb amplicons. For each amplicon, average expression +/2 SD at 25 mM glucose with negative control siRNA was
considered 100% and other values are shown relative to that. N=3 per group, p,0.001 at all glucose concentrations for ATF4, F7 and ASNS
amplicons, and for the C/EBPb amplicon at 0 mM glucose. B. Experiment as in panel A, except that C/EBPb siRNA (white bars) was used with negative
control siRNA (grey bars). C/EBPb siRNA had no effect on ATF4 amplicon expression at all glucose concentrations, but significantly blocked expression
and induction of C/EBPb at all glucose concentrations and induction of F7 at 0 mM glucose (p,0.001), N=3 per group.
doi:10.1371/journal.pone.0040994.g006
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PLoS ONE | www.plosone.org 8 July 2012 | Volume 7 | Issue 7 | e40994Figure 7. AARE mediates F7 glucose deprivation response. A. HepG2 cells were transfected with promoterless or reporter vectors OGH (N=6/
group), AARE-WT or DAARE (N=12/group), along with either negative control siRNA or ATF4 si#1, then cultured at 5 mM glucose for the final 24 hr
before harvest. Reporter expression is shown relative to that of AARE-WT vector in the presence of control siRNA, which was considered 100%. Effect
of ATF4 siRNA on expression from AARE-WT vector only, p,0.001. B. HepG2 cells were transfected with reporter vectors and incubated in medium
containing 25 mM glucose (dark grey bars), 5 mM glucose (light grey bars) or 0 mM glucose (white bars), with diminishing glucose concentration
depicted by wedges. Glucose deprivation increased expression from WT reporter (N=12; p,0.001), but not from DAARE (N=12/group) or OGH
(N=9/group) reporters. C. HepG2 cells were transfected with reporter vectors OGH, AARE-WT, DAARE, DAo rDC, along with 0 ng (dark grey bars),
125 ng (light grey bars) or 250 ng (white bars) of ATF4 expression plasmid, with increasing amounts depicted by the wedges. The number of
replicates per group is shown below each bar. Expression from AARE-WT reporter without recombinant ATF4 was considered 100%; expression from
the other groups are shown in comparison to this. Note the break in the Y-axis at 800%; expression from WT vector with ATF4 is graphed on the
upper portion, all other groups on the lower portion. All effects of ATF4 coexpression were significant (p,0.001).
doi:10.1371/journal.pone.0040994.g007
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half-motif compromised the ability of the AARE to function.
ATF4 Binds the F7 AARE
The ability of ATF4 as well as C/EBPb to directly bind to
AARE-spanning oligonucleotides was explored by EMSA with
recombinant human proteins overexpressed individually in COS-1
cells. As shown in Figure 8A, COS-1 cell extracts containing
recombinant ATF4 produced a complex with the AARE-WT
oligonucleotide, which was blocked and/or supershifted by an
anti-ATF4 antibody. Neither the DA nor the DC oligonucleotide,
however, was able to interact with ATF4. COS-1 cell extracts
expressing human C/EBPb were tested similarly, and the results
are shown in Figure 8B. Two complexes of differing mobilities
were observed binding to the unmutated F7 oligonucleotide.
Because the intronless C/EBPb mRNA has three alternative
initiation codons which can be selected by the cellular transcrip-
tional machinery to produce the isoforms LAP* (or LAP-1), LAP
(LAP-2), and LIP, a mixture of isoforms was expected. LAP* is the
full-length protein; the slightly smaller LAP lacks only the N-
terminal 23 amino acids. The truncated isoform, LIP, has DNA
binding and dimerization domains identical to the longer isoforms,
but lacks the entire N-terminal transactivation domain that they
both possess [66]. Both C/EBPb binding complexes observed in
EMSA were blocked/supershifted by a pan-C/EBPb antibody
recognizing all isoforms. While weak residual binding of C/EBPb-
containing complexes was retained by the DA oligonucleotide,
none was detectable with the DC oligonucleotide.
These data indicated that ATF4 as well as C/EBPb bound the
F7 AARE, with a requirement that both half-motifs be intact for
optimal binding to each transcription factor. The ability of
endogenous ATF4 in nuclear extracts of HepG2 cells to interact
with the AARE-WT oligonucleotide was examined next. As shown
in the EMSA of Figure 9, glucose deprivation increased the overall
detection of binding complexes and of a complex with slightly
altered electrophoretic mobility. This complex is more easily
discerned in the lighter exposure of lanes 1 though 7 shown on the
right side of the figure, which is , 20% of the intensity in the
longer exposure shown on the left. Inclusion of antibody to ATF4
produced a supershifted complex with components of the nuclear
extract prepared from glucose-deprived cells (lane 7), while
inclusion of antibody to C/EBPb blocked/supershifted the
majority of complexes binding to the AARE-WT oligonucleotide
under all glucose concentrations. The mobility of one complex
supershifted by the anti-C/EBPb antibody matched that of the
complex supershifted by the anti-ATF4 antibody, and was most
prominent in lane 9, containing nuclear extract prepared from
glucose-deprived cells. This same supershifted complex is also
detectable in lane 11, using nuclear extracts prepared from cells
incubated with 5 mM glucose.
The data of Figure 9 suggested that at least some binding
complexes from HepG2 nuclear extracts were heterodimeric
species comprised of one ATF4 monomer and one C/EBPb
monomer. However, we also considered an alternative possibility,
that individual binding complexes were composed of homodimers
of either ATF4 or C/EBPb isoforms, with one monomer binding
optimally to its preferred half-site in the AARE and the other
monomer interacting weakly but adequately with the non-
preferred half-site. These alternatives are testable using mixing
and supershift assays, provided the antibodies used do not cross-
react significantly. To confirm that the antibodies were sufficiently
specific for these experiments, reciprocal Western blotting of
COS-1 cell extracts individually overexpressing recombinant
Figure 8. Recombinant ATF4 and C/EBPb bind the F7 AARE. A. Oligonucleotides spanning F7 AARE without mutation (WT) or with mutation
in the ATF-motif (DA) or the C/EBPb-motif (DC), were incubated with 8 mg extracts of COS-1 cells that were untransfected, or transfected with
expression plasmid for human ATF4. Extract used in each lane, and the lanes in which anti-ATF4 antibody were included, are indicated. The arrow
indicates supershifted complex (ATF4 ss) detected in presence of antibody. B. A similar experiment, but using extract of COS-1 cells transfected with
expression plasmid for human C/EBPb in the absence or presence of anti-C/EBPb antibody. The arrow indicates position of the supershifted complex
(C/EBPb ss).
doi:10.1371/journal.pone.0040994.g008
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presented in Figure S2, demonstrated that each antibody
sensitively recognized the recombinant protein against which it
had been raised. There was no indication that the anti-ATF4
antibody recognized C/EBPb or that the anti-C/EBPb antibody
recognized ATF4. However, longer exposures of the blots showed
that COS-1 cells also contained a protein recognized by the anti-
C/EBPb antibody, suggesting that these cells express a similar
protein with nearly the same mass as human C/EBPb. This cross-
reacting protein can be seen faintly in lanes 1 and 2 of the anti-C/
EBPb blot of Figure S2.
Because mobility of oligonucleotide-protein complexes in
EMSA is primarily determined by the mass of the protein
constituents, we therefore performed the mixing experiment with
recombinant human ATF4 and LIP, the smallest of the C/EBPb
isoforms. (Figure 10) ATF4-LIP heterodimeric complexes would
be distinguishable from other potential dimeric complexes by
migration pattern as well as by antibody recognition, since LIP
monomers (,20 kDa) are dissimilar in mass compared to ATF4
(,50 kDa), LAP*/LAP (,45 kDa each) and the C/EBPb cross-
reacting protein from COS-1 cells. Figure 10 shows results
obtained when recombinant ATF4 or LIP were tested with the
AARE-WT oligonucleotide, individually and in combination. A
major complex of slow mobility (indicated by arrow 1) was
observed on the AARE-WT oligonucleotide when titrated with 2–
8 mg ATF4 extract. This complex was supershifted/blocked
completely by the anti-ATF4 antibody, and partially by the anti-
C/EBPb antibody. The 2 mg of LIP extract used in this
experiment was insufficient to produce a detectable complex at
this exposure level when tested individually (lane 7). However,
mixing of this amount of LIP extract with the titrated amounts of
ATF4 extract produced two strong, readily detectable complexes
of rapid mobility (arrows 2 and 3) and also intensified the original
band that had been seen with ATF4 extract alone (arrow 1).
Antibody directed towards either ATF4 or C/EBPb supershifted/
blocked all three complexes. Because combination of the two
extracts synergistically increased total binding to the AARE-WT
oligonucleotide and also produced prominent complexes of faster
mobility (hence smaller mass) that were recognized by both
antibodies, these data confirm that ATF4-C/EBPb heterodimers
are a F7 AARE binding species. We conclude that increased
expression of both ATF4 and C/EBPb, and their subsequent
interactions with the AARE of the F7 gene, are responsible for
upregulated F7 transcription and FVII secretion during glucose
deprivation.
Discussion
Blood coagulation is an important process that maintains the
integrity of the vascular system following injury. Coagulation is
controlled on multiple levels to restrict its location and extent to
sites of injury to the blood vessel wall. A major point of regulation
of coagulation is control over the first reactions of the pathway, the
interaction of FVII with its obligate receptor, TF. In order to
Figure 9. ATF4-containing complexes from glucose-deprived HepG2 cells bind F7 AARE. In each lane, 10 mg of nuclear extracts from cells
cultured with 25 mM, 5 mM, or 0 M glucose interacted with AARE-WT probe, in the absence and presence of anti-ATF4 or anti-C/EBPb antibodies.
The darker exposure is shown at left; an ATF4 supershifted complex in lane 7 is indicated by arrow (ATF4 ss). Two C/EBPb supershifted complexes are
seen in lanes 9 and 11, one of which has identical mobility to ATF4 ss and the other which is indicated by arrow (C/EBPb ss). In the lighter exposure of
lanes 4 through 7, shown at right, a binding complex with slightly increased mobility in the 0 mM glucose condition (lanes 6 and 7) is more easily
distinguished from the complexes of lanes 2–5 and indicted by arrow (new complex).
doi:10.1371/journal.pone.0040994.g009
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nents are not only required to come into contact but also to be
activated. Unlike TF, which is synthesized by many cell types, is
relatively abundant and is found primarily outside of the
bloodstream, FVII is synthesized in trace amounts by hepatocytes
and is found primarily within the bloodstream. Some FVII,
however, apparently extravasates from the circulatory system and
binds to TF in perivascular tissues. [67] Reduction of plasma FVII,
such as may result from hereditary defects in the F7 gene, cause
a bleeding disorder of variable severity. When FVII levels are
drastically reduced, the consequences of bleeding episodes can be
life threatening. As a protein with a low plasma concentration and
very short half-life, FVII must be consistently transcribed,
synthesized and secreted in order to maintain plasma levels within
an acceptable range for hemostasis.
Much work has shown that cellular stress conditions affect the
ability of cells to synthesize secreted proteins. One well-charac-
terized response to stressors including nutrient deprivation is
repression of global protein synthesis, which reduces the energetic
demands on the cells at a time when their resources are limited. In
the present study, which investigated the effects of glucose
deprivation on expression of coagulation protein expression, we
found that several coagulation protein genes behaved in just that
manner. As might be expected, their steady-state mRNA levels
declined after 24 hr of glucose deprivation. However, one
coagulation protein gene, encoding FVII, behaved in the converse
manner. The work presented here demonstrated that F7
expression (at both the mRNA and secreted antigen levels) was
significantly increased in cells deprived of glucose. In contrast to
the downregulation of expression of several other coagulation
proteins, the upregulation of F7 expression under glucose
deprivation resembled that of the stress responsive transcription
factors ATF3, ATF6, C/EBPb, XBP1(S) and CHOP, as well as of
the enzyme ASNS, the chaperone protein GRP-78, and the PP1
accessory factor GADD34. Previous work has examined the
expression of recombinant FVIII cDNA in non-hepatic cell lines
[68,69,70] and demonstrated that biosynthesis and secretion of the
large FVIII protein, which carries numerous post-translational
modifications, places taxing energetic demands even on cells that
are highly specialized for protein secretion. We found that
expression of endogenous F8 was downregulated in HepG2 cells
during glucose deprivation, as were F10, F2, and PROS1, all
contrary to F7. To our knowledge, this was the first investigation of
endogenous coagulation protein expression during cellular stress,
and indicated that F7 is regulated in an opposite manner to the
others under our experimental conditions.
We found that glucose deprivation elevated both the steady-
state F7 mRNA within HepG2 cells, as well as the amount of FVII
antigen secreted by them. Limitation of glucose was also associated
with upregulation at both the mRNA and protein levels of
transcription factor ATF4, and RNA interference experiments
demonstrated that upregulation of F7 mediated by glucose
deprivation was causally related to the upregulation of ATF4 as
well as of C/EBPb, an ATF4 target gene during cellular stress
responses. [45,71,72] Although a supporting role for C/EBPb,
which itself interacts with the F7 promoter [63] could not be ruled
out, it was clear that the ATF4 upregulation was ultimately
responsible for the increased endogenous F7 expression observed
during glucose deprivation. In an analogous manner, glucose
deprivation increased the expression of a reporter gene directed by
a fragment of native F7 promoter, and mutational analyses of that
fragment identified the amino-acid response element (AARE) as
the region responsible for increasing F7 reporter expression.
Lastly, EMSA performed with nuclear extracts from cells deprived
of glucose for 24 hr indicated that while the majority of AARE
binding complexes contained C/EBPb isoforms, a fraction also
included ATF4. Mixing and supershift experiments using
recombinant ATF4 and the truncated C/EBPb isoform LIP,
proteins of distinctly different masses, indicated that ATF4–C/
EBPb heterodimers can be formed on the AARE-WT oligonu-
cleotide. Unexpectedly, in the aggregate, these data indicated that
the F7 gene is a direct as well as indirect target of ATF4 in glucose-
deprived cells. The F7 gene directly interacts with and is
transcriptionally responsive to ATF4, a master regulator of cellular
stress responses.
The contribution of C/EBPb to F7 upregulation during glucose
deprivation cannot be overlooked. It should also be noted that,
although C/EBPb is strongly expressed in HepG2 cells even under
non-stressed conditions, we found that siRNA directed against C/
EBPb reduced F7 expression under glucose deprivation. This was
so, even though ATF4 induction was unaffected by the C/EBPb
siRNA, and though the overall extent of C/EBPb expression still
remained relatively high. Conversely, the siRNA directed against
ATF4 had a greater impact on F7 expression during glucose
deprivation than did the C/EBPb siRNA, perhaps because it
simultaneously diminished the upregulated expression of both
ATF4 and C/EBPb. These data imply not only that ATF4 and C/
Figure 10. AARE binding species include ATF4-C/EBPb hetero-
dimers. WT oligonucleotide probe spanning the F7 AARE was titrated
with 2 to 8 mg of extract from COS-1 cells overexpressing recombinant
human ATF4, in the absence (-) or presence (+)o f2mg of extract from
COS-1 cells overexpressing recombinant human LIP. Blocking/supershift
of binding complexes with anti-ATF4 and C/EBPb antibody are shown
without LIP in lanes 5 and 6 and with LIP in lanes 11 and 12. The bracket
(ss) indicates the region of the gel with supershifted complexes. 2 mgo f
LIP extract did not produce a detectable complex when tested alone
(lane 7).
doi:10.1371/journal.pone.0040994.g010
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most effectively under conditions when both are simultaneous
upregulated. As has been suggested, [73] it is possible that newly-
translated ATF4 and C/EBPb will tend to dimerize with other
newly-synthesized potential partners, making the formation of
ATF4-C/EBPb heterodimeric species more likely if both are being
concurrently synthesized, but formation of homodimeric species
more likely if synthesis of only one predominates at any given time.
Our data do not address whether all the endogenous C/EBPb-
containing binding complexes seen on EMSA are in heterodimeric
complexes, or whether additional C/EBPb binding partners
besides ATF4 might be present at the F7 AARE. Also, because
the anti-C/EBPb antibodies available for supershift analysis
cannot discriminate between the transcriptional activators
LAP*/LAP and the transcriptional inhibitor LIP, the data do
not address which C/EBPb isoforms are included. The broad
band of C/EBPb–containing complexes seen in all lanes of
Figure 7 suggests that multiple complexes of slightly different
masses exist within the cells and are capable of binding to the
oligonucleotide. Whether those differences in binding complex size
are due to the presence of different C/EBPb isoforms, carriage of
post-translational modifications, inclusion of additional binding
partners, or to a mixture of causes, is unknown. A previous study
of C/EBPb expression during ER stress in rat C6 glioma cells has
demonstrated that both the LAP and LIP isoforms are induced,
but that their relative proportions depend not only on the period of
stress but also on the nature of the stressor. [72] When stressed by
a poison such as thapsigargin or tunicamycin, the intracellular
levels of both LAP and LIP declined during the first three hours,
then rebounded and were significantly elevated between nine and
24 hours. The ratio between LAP and LIP also changed, with LAP
more prominent at the earlier times and LIP much more
prominent at the later times. Interestingly, a different pattern
was seen when cells were stressed in a more physiological manner.
LAP and LIP were induced in tandem over twelve hours of amino
acid deprivation and remained elevated to 24 hours; and the ratio
between the isoforms was stable over this time course. The
possibility that different stress conditions could produce subtle
variations in the mechanism and outcome of the stress response
itself is intriguing, and may have implications for the relative
expression of numerous downstream target genes.
In our experiments, the period of stress and the nature of the
stressor also influenced the outcome of coagulation factor
expression in HepG2 cells. When 24 hr glucose deprivation was
compared to 6 hr TG treatment, the ATF4 and C/EBPb genes
were upregulated comparably. However, under glucose depriva-
tion the expression of F7 was elevated and expression of F8 was
reduced, while under TG treatment neither F7 nor F8 expression
changed at all. Evidently, some critical difference in the cellular
response to glucose deprivation versus TG treatment supports the
different coagulation factor expression results obtained. Although
the reason(s) for this discrepancy in coagulation factor expression is
unclear, one caveat must be borne in mind: the C/EBPb gene
expression assay used in our experiments cannot distinguish
among the isoforms. Therefore it is not known whether C/EBPb
upregulation under glucose deprivation versus TG treatment
produced similar proportions of the isoforms LAP*/LAP and LIP.
ATF4 is induced to some degree under nearly all stress
conditions. Frequently, increased ATF4 transcription and prefer-
ential ATF4 translation occur together, coordinating to have
a large impact on the level of functional ATF4 transcription factor
generated. [60,73,74,75,76] Rarely, transcription of ATF4 is
found not to change or even to be reduced by a stressor. For
example, ultraviolet irradiation decreases ATF4 transcription, and
therefore ATF4 protein levels do not increase in UV-irradiated
cells despite high eIF2a phosphorylation [34,74]. An expanding
list of ATF4 target genes have now been identified, and many have
been shown to possess functional AAREs within their regulatory
regions, which mediate their transcriptional upregulation during
stress responses. Many of these ATF4 target genes are themselves
transcription factors needed to carry out the altered gene
transcription patterns of adaptive stress responses. Additional
ATF4 target genes encode proteins that alleviate a localized stress
in a straightforward manner. For example, genes encoding
asparagine synthetase as well as the system 2 neutral amino acid
and cystine-glutamate transporters, are induced in response to
glucose, amino acid or protein limitation. [37,41,43] These genes
are ubiquitously expressed and encode either intracellular or
membrane proteins, rather than secreted proteins. By increasing
the cellular capacity to synthesize amino acids or to acquire them
from the environment, the biological roles of the induced
enzymes/transporters are to directly counteract the nutritional
stress being experienced by the responding cells.
In contrast, there are other ATF4 target genes whose expression
is tissue-restricted, whose products are secreted from their cells of
origin, and whose roles in response to stress conditions are less
immediate or comprehensible. Such genes include osteocalcin,
insulin growth factor binding protein 1 and vascular-endothelial
growth factor. Osteocalcin is a calcium-binding component of
bone matrix produced by osteoblasts, which also acts as a hormone
for adipocytes and the pancreas. [77]. Insulin growth factor
binding protein 1 is a member of a family of secreted proteins that
regulate the activity of the insulin-like growth factors. Its
biosynthesis is tissue-restricted; liver, kidney, and female re-
productive organs are the major sites. [78,79] Vascular-endothelial
growth factor is a secreted protein expressed in response to low
oxygen tension, which acts as a mitogen via interaction with
endothelial cell surface receptors to promote and direct the growth
of new blood vessels. [80,81,82] Expression of these particular
stress-responsive target genes is required during various aspects of
development, growth, and tissue repair, and an AARE capable of
binding to ATF4 has been identified within a regulatory region of
each. Although the ATF6 and IRE1a branches of the stress
response were shown to contribute to upregulation of vascular-
endothelial growth factor, [82] it is evident that ATF4-dependent
mechanisms are primarily responsible for upregulation of these
genes under stress conditions.
Our work indicates that F7 is an additional example of a stress-
inducible gene with tissue-restricted expression, which encodes
a secreted protein having the potential to either maintain normal
systemic function despite the stressor and/or to modulate systemic
responses to the stressor. HepG2 cells stressed by lack of available
glucose devoted a portion of their limited resources to the
production of this coagulation protein, and then secreted it,
sustaining a net loss of material that might otherwise have been
directed to biochemical salvage pathways or to catabolism. It is not
completely clear why, among the coagulation factor genes tested,
expression of only the F7 gene was transcriptionally upregulated.
But considering its very short half-life in plasma in comparison to
other coagulation proteins and its essential role as a co-initiator of
blood coagulation along with TF, F7 upregulation could plausibly
be a compensatory mechanism to maintain adequate hemostasis
during periods of stress. Reductions in the plasma concentrations
of some procoagulant proteins, such as FX or prothrombin, with
half lives of 40–70 hr, might be expected to have a lesser potential
impact on hemostasis than reduction in the plasma concentration
of FVII, with its half life of 3–6 hr.
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complex plays both direct and indirect roles in signal transduction
processes of non-hepatic cells, which could also be affected by the
plasma level of FVII. The capacity of monocyte TF, a trans-
membrane protein with similarity to class 2 cytokine receptors, to
participate directly in signal transduction when stimulated by FVII
binding has been investigated following LPS stimulation, and
upregulated expression of pro-inflammatory cytokines such as IL-
6, IL-8 and TNFa was observed. [83]In addition, when bound to
TF on a cell surface, FVIIa has been shown to trigger signal
transduction through cleavage and activation of the G-protein
coupled receptor, protease-activated receptor 2. (reviewed in [84])
Some additional consequences of TF–FVII interactions, not all of
which relate to hemostasis, may be inferred from the results of
investigations performed with the ‘‘low-FVII’’ transgenic mouse,
which expresses ,1% of the average normal level of plasma FVII.
On the one hand, the low-FVII mouse suffers slower wound
healing, and is more prone to cardiomyopathy as a result of post-
hemorrhage fibrosis within the heart. [85,86] On the other hand,
the low FVII mouse experiences reduced experimental asthmatic
responses, and is more likely to survive LPS-induced endotoxemia.
[87,88] Comparison of the responses of the low-FVII mouse and
its normal-FVII counterpart to various challenges thus suggests
that the outcomes of the TF–FVII interaction may be alternately
beneficial or detrimental, especially in response to inflammatory
stimuli.
The data we present also showed that ATF4 steady-state
mRNA and protein were present and functional in HepG2 cells
even under nominally un-stressed conditions, indicating that
a degree of eIF2a phosphorylation continuously but transiently
takes place and then is resolved. Indeed, phospho-eIF2a was
detected by Western blot in cells even without glucose deprivation.
This is unlikely to be an idiosyncrasy of HepG2 cells, since it has
been shown that feeding acutely increases activation of stress
markers in the liver. [89,90] Indeed, ATF4 protein is detectable in
the livers of normal mice following a 12 hr fast, and is further
induced by a 4 hour continuous nutrient infusion supplying
approximately 50% of the typical daily caloric intake. [91].
That both fasting and feeding have both been linked to
upregulated ATF4 in hepatic cells from healthy animals, albeit to
different extents and perhaps with other permutations as well, is
intriguing. Such ATF4 oscillations may be transient in healthy
individuals but more sustained, or of different character, in those
with metabolic disorders affecting the liver that develop in-
sidiously such as diabetes. [90,92] Activation of ER stress
response pathways has been linked with establishment of hepatic
insulin resistance, which is a hallmark of diabetes, while
alleviation of that stress has been correlated with restoration of
insulin sensitivity. [93,94] In this regard, it is interesting to note
that plasma levels of coagulation proteins, including FVII, are
often elevated in diabetics [95] and that our previous work
demonstrated downregulation of F7 expression by insulin
treatment. [63] In the insulin-resistant state, the loss of such
negative regulation of gene expression would passively permit
increased F7 transcription to take place. However, the work
presented here implies that increased ATF4-dependent transcrip-
tion during the cellular stress elicited by insulin resistance might
comprise an additional positive regulatory mechanism contribut-
ing to elevated plasma FVII in diabetics. The physiological
implications of increased F7/FVII expression resulting from
glucose deprivation, or other stressors provoking ATF4 in-
duction, are deserving of further attention considering the
plieotropic effects of TF–FVII interactions.
Materials and Methods
Cell Culture and Treatments
The human hepatoma cell line, HepG2 (HB-8065), was
obtained from the American Type Culture Collection (Manassas,
VA) and routinely cultured in full growth medium as described
described [63]. For experimental treatments, 2610
5 cells were
plated per well in 6-well dishes, cultured to approximately 70%
confluence in full growth medium, then transferred for an
additional 24 hr to collection media, consisting of glucose-free
D-MEM (Sigma-Aldrich, St Louis, MO) containing 10% or 1%
(v/v) fetal bovine serum, and supplemented with D-glucose (Life
Technologies, Carlsbad, CA) to the desired final concentration.
Aliquots of the conditioned collection media were assayed for
secreted factor VII antigen by enzyme-linked immunoabsorbent
assay (ELISA) (Enzyme Research Labs, South Bend, IN). HepG2
whole cell lysates were prepared for Western blotting using RIPA
lysis and extraction buffer supplemented with HALT Protease and
Phosphatase Inhibitor cocktail (Thermo Fisher Scientific, Rock-
ford, IL). Thapsigargin (Calbiochem EMD Millipore, Billerica,
MA) at 500 nM final and Sal003 (Santa Cruz Biotechnology,
Santa Cruz, CA) at 10 mM final were added to cultures for 6 hr
where indicated. Nuclear extracts were prepared by hypotonic
lysis described [63] for use in EMSA. COS-1 cells (ATCC CRL-
1650) were routinely cultured in Dulbecco’s modified Eagle’s
medium (D-MEM; Life Technologies) plus 10% serum supple-
mented with 100 U/ml penicillin G, 100 mg/ml streptomycin at
37uC in an atmosphere of 5% CO2. Cell numbers were
determined by trypsinization and hemocytometer counting in
duplicate for individual replicate cultures. Metabolic activity was
indicated with the Cell-Titer assay (Promega, Madison, WI)
performed according to the manufacturer’s protocol. Additional
details for the Cell-Titer experiment are provided in Methods S1.
Reporter Constructs and Expression Plasmids
A human growth hormone (hGH) reporter plasmid containing
a segment of native F7 59 flanking sequence extending from
position 2728 to +134 relative to the translation start site of the
gene (with the initiation codon at positions +1t o+3), was
constructed in promoterless plasmid pOGH by PCR as described
[63]. Plasmids having block-mutated F7 AARE sequence
(DAARE, 59 ATGAGCGCA 39), and half-site mutated sequences
affecting only the ATF motif (DA, 59 ATTTCCGCA 39) or only
the C/EBP motif (DC, 59 AAGTCATCA 39) were made by
overlapping PCR using the native construct (WT, 59 ATTT-
CATCA 39) as the template. The AARE sequences from positions
28t o+1 are given, with mutated bases shown in bold type. All
plasmids were confirmed by DNA sequencing on both strands.
The expression vector for human C/EBP-LIP was the gift of Dr.
M. Kilberg (Gainsville, FL), while those for full-length human C/
EBPb and for ATF4 were obtained from Origene Technologies
(Rockville, MD).
Transfections
Transfection of HepG2 cells with hGH reporter plasmids and
b–galactosidase plasmid as a transfection efficiency control were
performed using Attractene (Qiagen Inc., Germantown MD) or
Lipofectamine (Life Technologies) according to the manufacturers’
protocols for this cell line. With Attractene, 3610
5 cells per well
were transfected in full growth medium at plating with 800 ng of
reporter vector and 200 ng of pRSV-b–galactosidase expression
vector. Approximately 40 hr later, the growth medium was
replaced with collection medium for an additional 24 hr prior to
harvest. Conditioned media and cell lysates were respectively
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TX; or Roche Applied Science, Indianapolis, IN) and for b–
galactosidase by colorimetric enzyme assay (Promega). Attractene
reagent was used for all DNA transfections except those shown in
Figure 7C, which were done with Lipofectamine reagent. In those
experiments, 1610
6 cells per well were plated in full growth
medium and transfected 18 hr later with a total of 4 mg of DNA.
2 mg of reporter vector, 0.5 mg of pRSV-b–galactosidase vector,
and 125 ng or 250 ng of human ATF4 expression plasmid were
introduced, with the total amount of DNA equalized by addition
of the inert plasmid, pUC19.
In all reporter gene assays, six replicates per reporter vector
were routinely done per experiment. Transfection data were
expressed as average percentage of normalized WT reporter
expression, plus or minus the standard deviation (SD). The
statistical significance of differences in reporter expression between
groups was assessed by the Student’s t-test.
5 nM small interfering RNA (siRNA) was introduced into
2.5610
5 HepG2 cells at plating using Hi-Perfect transfection
reagent (Qiagen) according to the manufacturer’s protocol. Cells
were cultured in full growth medium for approximately 40 hr
before transfer to collection medium for the final 24 hr incubation
prior to harvest. Six replicates were transfected per experiment,
with cells from pairs of wells combined for RNA preparation. The
siRNAs directed against human ATF4 (SI03019345 and
SI03218404) and human C/EBPb (SI02777292) were obtained
from Qiagen and used for targeted knockdowns. Negative and
positive transfection controls, the All-Stars negative siRNA and
All-Stars Death siRNA (also from Qiagen) were included in siRNA
experiments. The statistical significance of differences between
groups transfected with negative control siRNA and transcription
factor siRNA were assessed by the Student’s t-test.
For preparation of extracts overexpressing recombinant human
ATF4, C/EBPb or LIP, approximately 10610
6 COS-1 cells were
transfected with 10 mg of expression plasmid using Lipofectamine
reagent. The cells were cultured in full growth medium for 48 hr,
when whole-cell lysates were prepared by a freeze-thaw method.
[96].
Electrophoretic Mobility Shift Assay (EMSA)
Complementary oligonucleotides extending from position 220
to +25 of the F7 gene were annealed and end-labeled with
[c2
32P]-ATP (Perkin-Elmer Life Sciences, Billerica, MA) using
T4 polynucleotide kinase (New England Biolabs, Beverly MA).
Binding reactions were done in buffer containing 5 mM HEPES
pH 7.5, 30 mM KCl, 3 mM MgCl2, 0.5 mM EDTA, 0.5 mM
dithiothreitol, 12% glycerol, and 1 mg of poly (dI-dC). Incubations
of HepG2 nuclear extracts or COS-1 whole cell extracts with
radiolabeled probe were carried out for 15 minutes at room
temperature. For supershift, 60 min preincubation of extract in
binding buffer with antibody was done at 4uC preceded the
addition of probe. Reactions were electrophoresed on 5% (w/v)
polyacrylamide gels in tris-borate-EDTA buffer (90 mM Tris base,
90 mM sodium borate, and 0.5 mM EDTA) at 300 volts for 3 hr
with cooling to 4uC, then dried and autoradiographed.
For mixing experiments, COS-1-LIP whole-cell extract was
diluted in binding buffer and mixed with titrated amounts of COS-
ATF4 whole-cell extract for a 60 min preincubation period,
followed by probe addition and an additional 15 min incubation
period prior to electrophoresis. For supershift assays, polyclonal
antibodies to ATF4 or C/EBPb (sc-200X and sc-150X, Santa
Cruz Biotechnology) were added to reaction mixtures at the start
of the preincubation period.
Western Blotting
Whole-cell extracts of HepG2 cells were prepared following
experimental treatments as described, and of COS-1 cells at 48 hr
post transfection with recombinant expression vectors, respective-
ly. The protein concentrations were determined by the BCA
protein assay (Pierce Biotechnology, Rockford IL). Aliquots were
denatured in standard Laemmli sample buffer (Sigma, St. Louis
MO), separated on 4–20% discontinuous polyacrylamide gels
(ThermoFisherScientific) at 150 volts for 45 min at room
temperature, transferred to Immobilon membranes (Life Tech-
nologies) at 20 volts for 2 hr at 4uC, blocked overnight with 5%
(w/v) dry milk and 5% (w/v) bovine serum albumin, probed 2 hr
with appropriate primary antibody then 1 hr with horseradish
peroxidase-conjugated secondary antibody (Santa Cruz; Calbio-
chem, San Diego, CA), and developed with Dura-Signal West
chemiluminescent reagents (Pierce) at room temperature. Primary
antibodies to ATF4 and C/EBPb were the same as those used for
EMSA; antibodies to CHOP, ATF3, XBP1 (S), pan-eIF2a and
GAPDH were from Santa Cruz, while antibody to phospho-eIF2a
was from Cell Signaling Technologies (Beverly, MA). Experimen-
tal assessment of cross-reaction potential of the anti-ATF4 and
anti-C/EBPb antibodies is described in Methods S1.
Quantitative Reverse-transcriptase Realtime PCR
Total RNA was prepared by the RNeasy miniprep protocol
(Qiagen), and converted to cDNA using the High-Capacity RNA
to cDNA kit (Applied Biosystems, Foster City CA). Aliquots of
cDNA were tested in qRT-PCR using Taq-Man gene-specific
assay mixtures in an Applied Biosystems 7900 detector under
standard cycling conditions of 2 min at 48uC, 10 min at 95uC,
followed by 40 cycles of PCR with 15 sec at 95uC/1 min at 60uC.
This procedure was used to monitor relative expression of various
genes (ATF4, C/EBPb, ASNS, ATF3, GRP-78,CHOP, GADD34,
ATF6, XBP1(U), XBP1(S), F7, F8, FX, F2, PROS1; catalogue
numbers of gene expression assays given in Table S1) normalized
against expression of the 18S ribosomal RNA gene, by the DDCt
method. All values are percent expression +/2 SD. Unless
otherwise noted, the number of replicates per condition was three
per experiment, with each sample assayed in duplicate for each
amplicon. Statistical difference between groups was assessed by the
student’s t-test. qRT-PCR was also performed with two types of
control assay. Conversion reactions from which the reverse
transcriptase enzyme had been omitted were done to detect
DNA contamination of the RNA preparations, and no-template
controls were performed for each gene-specific assay. The controls
were always negative.
Supporting Information
Figure S1 Cellular characteristics. At left, cells were plated
on a 96-well dish, at cell numbers and culture medium volumes
proportional to those used in all other experiments. Collection
media with 5 mM or 0 mM glucose were applied at the usual
time, and the CellTiter reagent (Promega) was included and
assayed according to the manufacturer’s protocol. N=8 per
group, p,0.001. At right, a parallel experiment was set up on
6-well dishes with proportional initial cell numbers and media
volumes. At the final time, cells were trypsinized and counted
using a hemocytometer. The average of 8 cell count determina-
tions per well are shown; the difference between the 5 mM and
0 mM glucose groups was not significant.
(TIF)
Figure S2 Antibody specificity. 20 mg aliquots of extracts
from untransfected COS-1 cells, or cells individually overexpres-
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PLoS ONE | www.plosone.org 15 July 2012 | Volume 7 | Issue 7 | e40994sing recombinant human ATF4 or human C/EBPb (as shown
above lanes) were separated by SDS-PAGE and subjected to
Western blotting with anti-ATF4 or anti-C/EBPb antibody as
shown to the right of each panel. As loading controls, replicate
samples were blotted with anti-GAPDH antibody.
(TIF)
Table S1 Gene expression assays. The target genes used for
RT-PCR experiments are shown in the first column. The genbank
accession numbers, and Applied Biosystems/Life Technologies
gene expression assay numbers, are given for each target gene.
(DOC)
Methods S1 Detailed methodology for the experiments
shown in Figures S1 and S2 are provided.
(DOC)
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